Industry › Healthcare & Pharm

Press Releases

樂普生物2022年上半年聚焦核心管線開發，加速商業化落地

Aug 25, 2022 17:45 HKT/SGT

兆科眼科公布2022中期业绩

Aug 24, 2022 20:39 HKT/SGT

兆科眼科公佈2022中期業績

Aug 24, 2022 20:38 HKT/SGT

Zhaoke Ophthalmology Announces 2022 Interim Results

Aug 24, 2022 20:37 HKT/SGT

Avantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore

Aug 24, 2022 09:00 JST

中国抗体宣布SN1011针对视神经脊髓炎谱系疾病的新药研究申请获国家药监局批准

Aug 24, 2022 08:07 HKT/SGT

中國抗體宣佈SN1011針對視神經脊髓炎譜系疾病的新藥研究申請獲國家藥監局批准

Aug 24, 2022 08:06 HKT/SGT

Sinomab Announces IND Application of SN1011 for the Treatment of Neuromyelitis Optica Spectrum Disorder Approved by NMPA

Aug 24, 2022 08:05 HKT/SGT

Avantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore

Aug 24, 2022 07:55 HKT/SGT

Oculis公佈II期數據抗腫瘤壞死因子(anti-TNFa)眼藥滴劑利卡明利單抗(OCS-02)可緩解嚴重干眼病患者的持續眼部不適

Aug 23, 2022 20:38 HKT/SGT

Oculis announces publication of Phase 2 data showing topical eye drops anti-TNFa agent licaminlimab (OCS-02) relieves persistent ocular discomfort in severe dry eye disease

Aug 23, 2022 20:37 HKT/SGT

中国生物制药（1177.HK）公布2022年中期业绩，收入上升5.9%至人民币151.94亿元

Aug 23, 2022 19:53 HKT/SGT

中國生物製藥（1177.HK）公布2022年中期業績，收入上升5.9%至人民幣151.94億元

Aug 23, 2022 19:52 HKT/SGT

Sino Biopharmaceutical (1177.HK) Announces 2022 lnterim Results, Revenue up by 5.9% to RMB15.19 billion

Aug 23, 2022 19:51 HKT/SGT

沛嘉医疗公布2022年中期业绩：TaurusOne(R)及TaurusElite(R)屡创月度植入量新高

Aug 22, 2022 09:31 HKT/SGT

沛嘉醫療公佈2022年中期業績：TaurusOne®及TaurusElite®屢創月度植入量新高

Aug 22, 2022 09:30 HKT/SGT

Peijia Medical Announces 2022 Interim Results: TaurusOne(R) and TaurusElite(R) Repeatedly Sets New Monthly Highs in Implantation Volume

Aug 22, 2022 09:29 HKT/SGT

华检医疗控股公布二零二二年中期业绩

Aug 22, 2022 07:32 HKT/SGT

華檢醫療控股公佈二零二二年中期業績

Aug 22, 2022 07:31 HKT/SGT

IVD Medical Announces 2022 Interim Results

Aug 22, 2022 07:30 HKT/SGT